Back
ESC Premium Access

Impact of patients' wealth categories on antihypertensive drugs intake in 12 sub-saharan countries: EIGHT Study

Session: Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension
Topic: Guidelines and implementation in low resource settings
Speaker: Doctor M. Antignac (Paris, FR)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Marie Antignac

Hospital Saint-Antoine - INSERM PARCC, Paris (France)
0 follower

5 more presentations in this session

Prevalence of cardiomyopathy in patients with familial amyloid neuropathy: a report from the NEURO-TTR Trial

Speaker: Assistant Professor S. Heitner (Portland, US)

Access
Abstract
Slides
Thumbnail

Bortezomib: an effective therapy even in cardiac AL patients previously deemed unsalvageable

Speaker: Doctor A. Singh (Boston, US)

Access
Abstract
Slides
Thumbnail

Higher prevalence of hypertension in the migrant population in Italy: data derived from the 2012 and 2013 world kidney day

Speaker: Associate Professor S. Perlini (Pavia, IT)

Access
Abstract
Slides
Thumbnail

Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in hypertensive patients with diabetes treated with telmisartan plus diuretic

Speaker: Professor Y. Dohi (Nagoya, JP)

Access
Abstract
Thumbnail

Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan

Speaker: Associate Professor S. Chua (Kaohsiung, TW)

Access
Abstract
Slides
Thumbnail

Access the full session

Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Speakers: Doctor M. Antignac, Assistant Professor S. Heitner, Doctor A. Singh, Associate Professor S. Perlini, Professor Y. Dohi...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb